- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-10-0020978

Anaiva Therapeutics Private Limited
About Anaiva Therapeutics Private Limited
Data last updated:
Anaiva Therapeutics Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 11 June 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U74999MP2018PTC045993. Its GSTIN is 23AARCA0017D1ZA (Madhya Pradesh).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹21.2 Lakh. It is led by directors Smita Pagnis and Swapnil Pagnis.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at First Floor Plot No. 30 M.P. Nagar Zone – I, Bhopal, Madhya Pradesh, India – 462011.
As per the financials filed for FY 2025, the company reported a revenue of ₹32.58 Lakh, a decline of 72% compared to the previous year. For the same year it recorded a net loss of ₹6,677 (net margin -0.2%) and EBITDA of ₹20,066 (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years and 16% over five years.
As per MCA filings, the company has open charges of ₹93 Lakh on record.
Anaiva Therapeutics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-10-0020978).
Company details
Recognitions & Rankings of Anaiva Therapeutics
Contact details
Anaiva Therapeutics Private Limited's registered office is in Bhopal, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressFirst Floor Plot No. 30 M.P. Nagar Zone – I, Bhopal, Madhya Pradesh, India – 462011
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Anaiva Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Anaiva Therapeutics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Anaiva Therapeutics Private Limited, buy the company report.
Financials of Anaiva Therapeutics Private Limited
FY 2025 filings availableAnaiva Therapeutics Private Limited reported revenue of ₹32.58 Lakh (down 72% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 72% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 16%. EBITDA fell 85% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20,066 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6,677 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | ||||
| Net Profit Margin | -0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Anaiva Therapeutics Private Limited, buy the company report.
Board of directors of Anaiva Therapeutics Private Limited
Anaiva Therapeutics has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Smita Pagnis | Director | 20 Oct 2018 | 8 Years 1 Months | Current |
| Swapnil Pagnis | Director | 11 Jun 2018 | 8 Years 5 Months | Current |
Peer comparison
Anaiva Therapeutics Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| MHS Decor Private Limited | ₹32.6 Lakh (FY 2025) | -27.0% | Saharanpur, Uttar Pradesh, India | |||
| TBS Seeds Private Limited | ₹32.6 Lakh (FY 2024) | Hyderabad, Telangana, India | ||||
| Manzara Medicos Private Limited | ₹32.59 Lakh (FY 2025) | -11.0% | Delhi, India | |||
| Vet Sciences Private Limited | ₹32.59 Lakh (FY 2023) | 14.0% | Patna, Bihar, India | |||
| Monabas Vikassheel Kisaan Producer Company Limited | ₹32.59 Lakh (FY 2023) | Bandikui, Rajasthan, India | ||||
| Anaiva Therapeutics Private Limitedthis company | ₹32.58 Lakh (FY 2025) | -₹6,677 | -0.2% | -72.0% | Bhopal, Madhya Pradesh, India | |
| Tarasha Plywood Private Limited | ₹32.58 Lakh (FY 2019) | -90.0% | Kolkata, West Bengal, India | |||
| Mipco Commotrade Pvt.Ltd. | ₹32.58 Lakh (FY 2025) | -3.0% | Kolkata, West Bengal, India | |||
| Shivpariwar Tradelink Private Limited | ₹32.58 Lakh (FY 2024) | 1288.0% | Kolkata, West Bengal, India | |||
| Om Aarham Furnishing Private Limited | ₹32.57 Lakh (FY 2021) | Raipur, Chhattisgarh, India | ||||
| Supreme Tyres Pvt Ltd | ₹32.57 Lakh (FY 2025) | 0.0% | Shillong, Meghalaya, India |
To see the full peer comparison of Anaiva Therapeutics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 May 2019 | 100269554 | Others | ₹93 Lakh | Open |
To see the full charge records of Anaiva Therapeutics Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Anaiva Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anaiva Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Anaiva Therapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AARCA0017D1ZA | Madhya Pradesh | Active | 27 Jul 2018 |
To see the full GST registrations and return filing status of Anaiva Therapeutics Private Limited, buy the company report.
Recent activity
Anaiva Therapeutics Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Ruby Tripathi ceased to be Director on 28 Sep 2021.
Frequently asked questions
Anaiva Therapeutics is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 11 June 2018 (8+ years old) and is registered under CIN U74999MP2018PTC045993.
Anaiva Therapeutics has 2 current directors:
- Smita Pagnis - Director
- Swapnil Pagnis - Director
The latest financial statements of Anaiva Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Anaiva Therapeutics is 23AARCA0017D1ZA, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Anaiva Therapeutics is U74999MP2018PTC045993. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anaiva Therapeutics was incorporated on 11 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Anaiva Therapeutics by revenue are MHS Decor Private Limited, TBS Seeds Private Limited, Manzara Medicos Private Limited, Vet Sciences Private Limited, Monabas Vikassheel Kisaan Producer Company Limited and 5 more, all in the same principal business activity (wholesale trading).
Ruby Tripathi ceased to be Director on 28 Sep 2021. Atul Bali ceased to be Director on 22 Oct 2018. Smita Pagnis was appointed as Director on 20 Oct 2018. Anaiva Therapeutics has 4 board changes on record in total.
Yes, Anaiva Therapeutics is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-10-0020978).
The registered office of Anaiva Therapeutics is at First Floor Plot No. 30 M.P. Nagar Zone – I, Bhopal, Madhya Pradesh, India – 462011.
Anaiva Therapeutics operates in the business services industry, in the miscellaneous business activities segment.

